Provided by Tiger Trade Technology Pte. Ltd.

Weight Loss Drugs

1,567.99
-10.0364-0.64%
Number of Gainers:- -
Number of Losers:7
Number of Flat:- -
PE:- -
High:1,590.89
Open:1,579.34
Low:1,558.46
Close:1,578.03
Volume:63.28M
Turnover:5.40B
Market Cap:1.63T
Float Cap:1.57T

Loading ...

Eli Lilly: Breaks Ground on Fifth U.S. API Manufacturing Site in Houston

THOMSON REUTERS
·
Sep 22

Eli Lilly: Houston Facility to Manufacture Active Pharmaceutical Ingredients for Medicines Like Foundayo

THOMSON REUTERS
·
Sep 22

NYSE Net Change Percentage Gainers & Losers

Dow Jones
·
Sep 22

Pharmaceutical Companies Push Trump Administration to Protect China Deals

Dow Jones
·
Sep 22

Biogen Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Sep 22

Sector Update: Healthcare

MT Newswires Live
·
Sep 22

Viking Therapeutics Currently Down 10 Consecutive Days, on Pace for Longest Losing Streak Since September 2023

Dow Jones
·
Sep 22

Eli Lilly CEO tells CNBC one-third of new GLP-1 pill patients taking Foundayo

TIPRANKS
·
Sep 22

Pfizer’s Rimegepant Trial Targets Chronic Migraine Market Upside

TIPRANKS
·
Sep 22

Pfizer Advances PF-07799544 With Completion of Key Phase 1 Study

TIPRANKS
·
Sep 22

European Stocks Close Higher Monday as Oil Prices Tumble

MT Newswires Live
·
Sep 22

Novo Nordisk A/S Series B Stock Falls Monday, Underperforms Market

Dow Jones
·
Sep 22

Top Midday Stories: Paramount Skydance Settles With US States to Pave Way for Warner Bros. Deal; Anthropic Now Eyeing November IPO

MT Newswires Live
·
Sep 21

Novo Nordisk Details Progress on DKK 15 Billion Share Buyback Programme

TIPRANKS
·
Sep 21

European Equities Traded in the US as American depositary Receipts Rise in Monday Trading

MT Newswires Live
·
Sep 21

Cboe data shows mixed options sentiment in Novo Nordisk with shares down 7.85%

TIPRANKS
·
Sep 21

Novo Nordisk Says New Obesity Drug Outperformed Lilly's Zepbound in Phase 3 Trial

Dow Jones
·
Sep 21

Novo Nordisk A/S Stock (NVO) Moved Down by 7.86% on Sep 21: A Full Analysis

TradingKey
·
Sep 21

Novo Stock (NVO) Sinks Despite Beating Eli Lilly in New CagriSema Obesity Trial

TIPRANKS
·
Sep 21

Sector Update: Healthcare

MT Newswires Live
·
Sep 21